Companies · Other Health Care
CLAYMONT · Other Health Care
Diligence memoA one-page analyst read on AVP Holdings, LLC / Delaware — recommendation, valuation, rhythm, risks.→AVP Holdings, LLC / Delaware looks under-valued against its niche peers and is active on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
AVP Holdings, LLC / Delaware behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
AVP Holdings, LLC / Delaware is one of 5376 Other Health Care companies tracked from CLAYMONT. By capital raised it ranks mid-pack (ahead of 50% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 50% of sector peers (real $). Modeled value above 32% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #53 of 83.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| HelloJoy, Inc. | Series A | $26.3M | $55.0M | 3.37× |
| Maui Imaging, Inc. | Series A | $29.9M | $51.0M | 3.12× |
| Celltrio, Inc. | Series A | $15.0M | $50.8M | 3.11× |
| Medmo, Inc. | Series A | $31.7M | $44.7M | 2.74× |
| Vertical Orthopaedics, Inc. | Series A | $16.7M | $44.0M | 2.69× |
| AbriCare, Inc. | Series A | $15.0M | $39.1M | 2.39× |
| WP Stillwater, LLC | Series A | $14.3M | $38.1M | 2.33× |
| Sylke, Inc. | Series A | $15.9M | $37.6M | 2.30× |
| Iridex Corp | Series A | $10.0M | $37.2M | 2.28× |
| 2GHealth Inc. | Series A | $17.5M | $35.6M | 2.18× |
| Okc Alf 4, Llc | Series A | $8.9M | $34.5M | 2.11× |
| HC Jones, Inc. | Series A | $14.1M | $33.4M | 2.04× |
| AVP Holdings, LLC / Delaware this company | Series A | $2.4M | $8.9M | 0.55× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $9.8M | 2025-02-26 | $44.8M | $37.4M | 90% |
| Series A | $2.4M | 2025-03-11 | $10.8M | $8.9M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Sean O'Brien | — | 6 other | 2025-02 |
| William Wagner | — | 2 other | 2025-02 |
| Andrew Charnesky | — | — | 2025-02 |
| Dzmitry Miranovich | — | — | 2025-02 |
| Ian Sutcliffe | — | — | 2025-02 |
AVP Holdings, LLC / Delaware is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Diversity Holdings, LLC | Other Health Care | Series A | $4.2M | $9.9M | same sector · same stage |
| Houghton Investments, LLC | Other Health Care | Series A | $4.2M | $9.9M | same sector · same stage |
| Vestiage, Inc. | Other Health Care | Series A | $4.4M | $10.3M | same sector · same stage |
| Bergen County Asset Leasing, LLC | Other Health Care | Series A | $4.5M | $10.6M | same sector · same stage |
| Arlington Heights Memory Partners LLC | Other Health Care | Series A | $4.5M | $10.6M | same sector · same stage |
| Inovise Medical Inc | Other Health Care | Series A | $5.8M | $9.1M | same sector · same stage |
| Medical Connections Holdings, Inc. | Other Health Care | Series A | $6.5M | $10.6M | same sector · same stage |
| simplifyMD, Inc. | Other Health Care | Series A | $6.7M | $10.1M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Avia Holdings, Llc | Other Health Care | Series A | $272.7M | 88% |
| Advantage AVP Parent Holdings, L.P. | Other Health Care | Series D+ | $4.6M | 86% |
| Virginia Physician Holding Company, LLC | Other Health Care | Pre-Seed | $4.4M | 85% |
| AVG Holdings, Inc. | Other Health Care | Series A | $282.5M | 84% |
| VPP Group Holdings, L.P. | Other Health Care | Seed | $6.8M | 84% |
| PDC Holdings, LLC | Other Health Care | Seed | $32.6M | 83% |
| Mdp Acm Holdings, Llc | Other Health Care | Series C | $1.4B | 83% |
| AvoMD, Inc. | Other Health Care | Series A | $67.6M | 83% |
See where AVP Holdings, LLC / Delaware sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at AVP Holdings, LLC / Delaware, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.